NDC 69489-411

Qbrexza

Glycopyrronium

Qbrexza is a Topical Cloth in the Human Prescription Drug category. It is labeled and distributed by Journey Medical Corporation. The primary component is Glycopyrronium Tosylate.

• Product ID: 69489-411_11d0f4ba-c816-4772-ab5a-2e31c8577f45
• NDC: 69489-411
• Product Type: Human Prescription Drug
• Proprietary Name: Qbrexza
• Generic Name: Glycopyrronium
• Dosage Form: Cloth
• Route of Administration: TOPICAL
• Marketing Start Date: 2018-06-28
• Marketing Category: NDA /
• Application Number: NDA210361
• Labeler Name: Journey Medical Corporation
• Substance Name: GLYCOPYRRONIUM TOSYLATE
• Active Ingredient Strength: 2 g/100g
• Pharm Classes: Anticholinergic [EPC], Cholinergic Antagonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 69489-411-30

30 POUCH in 1 CARTON (69489-411-30) > 2.8 g in 1 POUCH (69489-411-01)

• Marketing Start Date: 2021-12-03
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Qbrexza" or generic name "Glycopyrronium"

NDC	Brand Name	Generic Name
69489-411	Qbrexza	glycopyrronium
70428-011	Qbrexza	glycopyrronium